The present invention relates to: (a) Formula 1 compounds (R1 to R5).A. Acceptable salts or solutions for inhibiting dopamine-beta-hydroxy-formate (b) pharmaceutical ingredients purchased by himRelease of these compounds, salts or solutions; (c) Use of these compounds, salts or solutions in treatment; (d) Treatment with these compounds.(e) Processes and intermediates for the synthesis of these compounds.
展开▼
